This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...
The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.
Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB (BE:UCB) in 2023, while Joerg Hornstein has been in post as chief finance ...
Two USAMRICD researchers have been awarded the federal government’s highest honor for outstanding early career scientists and ...